control group:bismuth quadruple therapy

4 trials

Sponsors

Sichuan Cancer Hospital, Department of Gastroenterology,Army Medical Center of PLA (Daping Hospital), Army Medical Center of PLA, The Affiliated Hospital of Southwest Medical University

Conditions

Gastric HP infectionHelicobacter pylori infectionInfection of H.pylorirefractory helicobacter pylori infection

Phase 4

Comparative study for the efficacy of different therapeutics in the treatment of gastric HP infection and effect on the distribution of gastral and intestinal flora: a randomized controlled prospective study

Active, not recruitingChiCTR1900025800

Sichuan Cancer HospitalGastric HP infection

Start: 2019-09-15Updated: 2019-09-16

A multicenter randomized controlled trial of optimised dual therapy and quadruple therapy containing metronidazole bismuth in newly treated patients with Helicobacter pylori

RecruitingChiCTR2000039096

Department of Gastroenterology,Army Medical Center of PLA (Daping Hospital)Helicobacter pylori infection

Start: 2020-10-28Updated: 2021-01-18

A multicenter randomized controlled study: the eradication of Helicobacter pylori infection by therapy of Vonoprazan-Minocycline.

RecruitingChiCTR2500098536

Army Medical Center of PLAInfection of H.pylori

Start: 2025-02-10Updated: 2025-03-17

Unknown Phase

Evaluation of the effectiveness and safety of fecal microbiota transplantation in the treatment of refractory Helicobacter pylori infection: a multicenter controlled study

RecruitingChiCTR2500101347

The Affiliated Hospital of Southwest Medical Universityrefractory helicobacter pylori infection

Start: 2025-05-01Updated: 2025-04-28

Related Papers

Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy <i>versus</i> bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> infection: a multicenter, randomized controlled clinical trial.

2022-12-265 citations

Efficacy of quadruple regimen with polaprezinc for gastric <i>Helicobacter pylori</i> infection eradication: protocol for a single-centre, single-blind, non-inferiority, randomised clinical trial

BMJ Open2020-11-012 citations